A randomized trial of amphotericin B (AB) alone and in
combination with oral itraconazole (IZ) is carried out in two
groups of 10 mucocutaneous leishmaniasis patients from Bolivia
and Peru. AB+IZ combination is no better than AB monotherapy,
as far as efficacy and tolerability are concerned. No
antagonism was detected.